JPX and esophageal squamous cell carcinoma: We showed that JPX promoted ESCC cell proliferation, migration, and invasion via the miR-516b-5p/VEGFA pathway, which might provide a promising novel diagnostic biomarker and therapeutic target for ESCC in clinic.